Clinical Trials Browser

Ovarian Neoplasms × Bendamustine Hydrochloride × 90 days × Clear all

NCT06483048 2026-03-16

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Phase 1 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms